The Reference-scaled Average Bioequivalence (RSABE) Approach
We examine the Reference-scaled Average Bioequivalence (RSABE) approach for generic drug development and how it…
Certara2025 年 7 月 1 日
Certara Enhances Integral Data Repository with Powerful REST API Capabilities in Version 25.4.1
Radnor, PA – 2025 年 6 月 20 日 - Certara, Inc. （纳斯达克股票代码：CERT), a global leader in…
Danielle Pillsbury2025 年 6 月 20 日
Latest Phoenix PK/PD analysis & modeling platform release prioritizes efficiency, power
2025 年 6 月 16 日 RADNOR, PA – 2025 年 6 月 16 日 – Certara, Inc. （纳斯达克股票代码：CERT), a…
Certara2025 年 6 月 16 日
Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer
The study, published in the Journal of Clinical Pharmacology, evaluates the cardiac safety of fruquintinib,…
Certara2025 年 6 月 8 日
On-Demand Webinar: Streamlining Population PK Modeling with Phoenix NLME and Pirana
Phoenix NLME offers unparalleled flexibility and power for PK/PD analyses, meeting all scientific and technical…
Danielle Pillsbury2025 年 6 月 5 日
Transform Your PK/PD Workflow with AI and the Cloud
Watch our on-demand webinar to see how AI and cloud technology will revolutionize your daily…
Danielle Pillsbury2025 年 6 月 5 日
